This supplement states it is formulated to double GLP-1 levels with clinically backed prebiotic fiber
Experts told Newsweek that the step to expand access to these medications was necessary and importantbut that GLP-1 drugs alone would not be enough
Lira FS, Rosa JC, Zanchi NE, Yamashita AS, Lopes RD, Lopes AC, et al
Certificate of Analysis (CoA): Per-batch testing documentation
GLP-1 medications like Ozempic, Wegovy, Zepbound, and Mounjaro have become household names, adding a new dynamic to the conversation around weight loss
Interestingly, OSA has been associated with impaired glucose metabolism in nonobese individuals (even after adjusting for generalized or visceral adiposity), while insulin-treated diabetic patients (especially women) experienced higher risk of OSA [23, 24]